O/D Vision is raising funds on Wefunder at an $8.7 million valuation. While the company has an innovative product in Tricorder.Zero, a portable health and fitness tracker with seven sensors, the valuation seems inflated for a pre-revenue company. O/D Vision has completed a working proof-of-concept prototype and holds two US patents, pending patents for over 12 concepts. However, without any users or revenue, it is challenging to assess the product's true market potential and scalability. Investors should carefully consider the valuation in relation to the company's current stage and lack of traction. The price rating for O/D Vision is relatively low due to the high valuation without a proven revenue model or user base.

The ongoing integration of digital technology in healthcare has led to a surge in the digital patient monitoring devices market. Bolstered by the increased prevalence of chronic diseases and the need for remote and home healthcare services, this market is expected to reach a value of $46.49 billion in the US in 2023. The market is characterized by a significant growth rate of 24.9%.

However, the healthcare industry is highly regulated, and gaining regulatory approval can be time-consuming and challenging as a potential entry barrier. Furthermore, the competitive landscape in the healthcare and fitness tracking market is extremely competitive, with several established brands already offering similar services. O/D Vision must differentiate its product and build strong partnerships with health providers and fitness trainers to gain a competitive edge.

O/D Vision is led by CEO Marcus Charles Bernard Soori-Arachi. Soori-Arachi has a background in the healthcare and pharmaceutical industry, with three years of relevant industry experience. He is a part-time founder and CEO of O/D Vision. While he doesn't have high-level managerial skills (i.e. no prior C-Suite positions), his experience in the industry will be valuable in guiding the company's growth.t.

Currently, the team consists of two members, including the CEO. The small team size indicates that O/D Vision is in the early stages of development. However, the company has six relevant advisors, which suggests they seek external expertise to support their growth and product development efforts.

O/D Vision is entering a highly competitive market with its Tricorder.Zero device. O/D Vision highlights its seven accurate sensors, medication tracking capabilities, and the ability to send data to health providers and fitness trainers. These features offer a more comprehensive and holistic health and fitness tracking approach than typical fitness trackers.

One potential differentiator for O/D Vision is its focus on the growing need for telehealth and fitness solutions. With the rise of remote healthcare and the increasing popularity of fitness tracking, O/D Vision aims to capture a share of the market by offering a device that combines both functionalities. The company has also taken steps to protect its intellectual property, securing two US patents and pending patents for over 12 concepts.

While O/D Vision's differentiation level is described as high, it is important to note that the company is still in the early stages of development and has not yet generated revenue or attracted paying customers. Additionally, the competitive landscape in the digital patient monitoring devices market is extremely competitive, with many direct competitors. This challenges O/D Vision to stand out and gain market share.

O/D Vision has progressed in its product development, having completed a working proof-of-concept prototype for Tricorder.Zero. The company holds two US patents and has several pending patents for additional concepts. These patents provide O/D Vision a competitive advantage and protect its intellectual property.

Despite its innovative product offering, O/D Vision has yet to generate revenue. The company does not currently have any paying customers, and its revenue for the fiscal year is $0. O/D Vision has a monthly burn rate of $1,188.98, indicating ongoing expenses without corresponding revenue.

O/D Vision has raised $301,600 in prior funding rounds, and its cash and cash equivalents at the end of the most recent fiscal year were $55,223.97.

As an early-stage company, O/D Vision faces a highly competitive landscape in the healthcare and fitness industries. The success of Tricorder.Zero will depend on the company's ability to attract customers and establish partnerships in the future.

Investing in O/D Vision comes with several risks that potential investors should consider. First, the company is still in the pre-revenue stage, so there is uncertainty about its ability to generate significant revenue soon. Additionally, O/D Vision's product, Tricorder.Zero, is still in the prototype stage, which introduces risks related to production and quality control. The company must successfully navigate the challenges of scaling production to meet market demand. The company must differentiate itself from established players and attract a significant user base to achieve sustainable growth. Another risk factor is the likelihood of facing legal issues. The healthcare industry is heavily regulated, and O/D Vision's operations in the telehealth and fitness space may subject it to stringent market approval and licensing regulations. Finally, O/D Vision's valuation may be perceived as overvalued, which could impact investors' potential return on investment. 

O/D Vision is positioned to disrupt the telehealth and fitness industry with its innovative product offering, Tricorder.Zero. The device, equipped with seven accurate sensors, revolutionizes health and fitness tracking by providing comprehensive, holistic data tracking capabilities. With Tricorder.Zero, users can actively monitor their health and fitness wherever they are, breaking the limits of typical fitness trackers.

The potential market for digital patient monitoring devices is high, and O/D Vision has identified a unique niche. The company's focus on telehealth and fitness aligns with the growing demand for remote healthcare solutions. Tricorder.Zero's ability to track medication usage and seamlessly send data to healthcare providers and fitness trainers sets it apart from competing products.

O/D Vision has demonstrated its commitment to innovation and intellectual property protection with two US patents and pending patents on over 12 concepts. This shows the company's dedication to staying ahead of the curve and continuously improving its product offering. With the completion of the working proof-of-concept prototype for Tricorder.Zero, the company is one step closer to bringing its innovative product to market.

Despite the highly competitive landscape, O/D Vision's unique product offering, focus on telehealth and fitness, and commitment to innovation and intellectual property protection give the company a competitive advantage. As the telehealth and fitness industries continue to grow, O/D Vision has the potential to become a key player in this evolving market.

O/D Vision is a technology company operating in the competitive healthcare and telehealth industry. While the company has developed a prototype device called Tricorder.Zero, it has no revenue and no users at this stage. As a pre-revenue company, O/D Vision relies solely on its crowdfunding campaign to generate capital for its operations and product development.

Furthermore, the company's valuation of $8.7 million seems significantly inflated, considering its current stage and lack of market traction. It is difficult to justify such a high valuation with no users, no partnerships, and no revenue. 

Additionally, O/D Vision is operating with a negative net income, indicating spending more than it generates. The company's monthly burn rate of $1,188.98 further raises concerns about its financial sustainability in the long term.

Given the highly competitive nature of the healthcare and telehealth industry and the company's lack of market presence, it is uncertain whether O/D Vision will be able to compete and capture market share effectively.

O/D Vision is a technology company capitalizing on the growing need for telehealth and fitness. The company has developed Tricorder.Zero, a pocket-sized health and fitness tracker with seven built-in sensors for comprehensive health data tracking. 

Despite being in its early stages, O/D Vision has already secured two US patents and has over 12 concepts pending. The company has also completed a working proof-of-concept prototype for Tricorder.Zero. However, it's worth noting that the company is pre-revenue and operates in an extremely competitive market.

The company's valuation of $8.7 million appears to be overvalued, given its current stage of development and lack of revenue. The company's monthly burn rate is $1,188.98, and it reported a net income of -$14,267.79 in the most recent fiscal year. The funds from the current crowdfunding campaign, which aims to raise between $50,000 and $300,000, will be used to bring the product to market.

While O/D Vision's product offering is innovative and meets a current market need, potential investors should consider the company's early stage, lack of revenue, and the competitive landscape in which it operates.